Bavarian Nordic Adopts Optimistic Outlook Amid New Orders for Mpox Vaccine

The Danish biotech on Thursday reported stronger-than-expected earnings and forecasts hitting the upper range of its full-year revenue target amid the ongoing mpox outbreak.